Inclisiran safely reduces LDL-C in primary prevention patients with elevated levels: Study Medha Baranwal19 Nov 2022 11:45 AM ISTTwice-yearly maintenance dosing with inclisiran significantly reduces LDL-C and other atherogenic lipoprotein measurements in patients without...
Short bursts of vigorous activity associated with increased longevity Dr. Kamal Kant Kohli29 Oct 2022 4:00 AM ISTResearchers have found in a new study that short bursts of vigorous activity were linked with increased longevity. Two minute bursts of vigorous...
Lowering blood pressure in later life can prevent dementia, study provides strong evidence Dr. Kamal Kant Kohli27 Oct 2022 12:15 PM ISTDementia is fast becoming a global epidemic with ever increasing incidence and it is projected to triple by 2050-mainly driven by aging...
Illicit drug use associated with increased risk of Atrial Fibrillation Dr. Kamal Kant Kohli19 Oct 2022 6:30 PM ISTAtrial fibrillation (AF) is now regarded as a preventable disease, requiring a search for modifiable risk factors. Researchers at UC San Francisco...
Riociguat significantly improves haemodynamics in patients with pulmonary hypertension with HFpEF: DYNAMIC Trial Dr. Kamal Kant Kohli17 Oct 2022 11:15 AM ISTEUROPE: According to a study published in the European Heart Journal, the vasodilator riociguat enhanced haemodynamics in patients with pulmonary...
Lp(a) as a causal risk factor for cardiovascular outcomes -- ESA consensus statement strengthens evidence Medha Baranwal2 Oct 2022 10:45 PM ISTEurope: The European Atherosclerosis Society (EAS) has released a recent consensus statement on lipoprotein(a) in atherosclerotic cardiovascular...
Double dose influenza vaccination may not improve cardiopulmonary outcomes in acute coronary syndrome Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTBrazil: A new study conducted by Henrique Andrade R Fonseca and his team showed that receiving two doses of the influenza vaccine before discharge did...
Empagliflozin proves beneficial in acute myocardial infarction: EMMY trial Dr. Kamal Kant Kohli11 Sept 2022 7:30 PM ISTAUSTRIA: Acute myocardial infarction (MI) patients who receive the SGLT2 inhibitor empagliflozin (Jardiance) early after the MI have improved markers...
ESC 2022 Ventricular Arrhythmia Guidelines - Key takeaways Medha Baranwal9 Sept 2022 10:00 AM ISTEurope: The European Society of Cardiology (ESC) has released updated guidelines on the management of patients with ventricular arrhythmias (VAs) and...
Higher Aldosterone levels increase risk of CKD progression independent of diabetes status Dr. Kamal Kant Kohli10 Aug 2022 8:00 PM ISTAldosterone is a steroid hormone secreted by the adrenal glands whose main role is to regulate salt and water in the body. It plays a central role in...
Lipoprotein(a) levels tied to onset of aortic valve calcification, not progression: Study Medha Baranwal10 Aug 2022 11:00 AM ISTNetherlands: Lipoprotein(a) is robustly associated with the development of aortic valve calcification (AVC) but not with the progression of...
Aldosterone increases risk of chronic kidney disease progression Dr. Nandita Mohan9 Aug 2022 9:00 AM ISTA steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease. This is in accordance...
